Related Experiment Videos
Neuropathology, cell biology, and newer diagnostic methods
J M Bruner1, L A Langford, G N Fuller
1Department of Pathology, University of Texas MD Anderson Cancer Center, Houston 77030.
Current Opinion in Oncology
|May 1, 1993
Summary
This study correlates molecular changes in brain tumors with clinical outcomes, comparing genetic alterations and proliferation markers to understand tumor behavior and guide therapy. Findings aim to validate methods for predicting patient prognosis in gliomas and meningiomas.
Area of Science:
- Neuro-oncology
- Molecular pathology
- Genetics
Background:
- Molecular events in brain tumors correlate with clinical outcomes.
- Previous studies identified alterations in tumor-suppressor genes, growth factors, and enzyme systems in gliomas.
- Current research investigates the relationship between these molecular changes and tumor grade, growth rate, and therapeutic response.
Purpose of the Study:
- To compare specific molecular events in gliomas, including genetic heterozygosity loss on chromosomes 10 and 17p, epidermal growth factor receptor gene alterations, and protein kinase C changes.
- To correlate chromosomal changes with histologic features in meningioma.
- To compare and validate various methods for measuring tumor cell proliferation and their correlation with clinical outcome.
Main Methods:
- Analysis of genetic heterozygosity on chromosomes 10 and 17p.
- Assessment of epidermal growth factor receptor gene amplification and rearrangement.
- Evaluation of protein kinase C enzyme system changes.
- Histologic examination of meningiomas with correlation to chromosome 22 changes.
- Comparison of proliferation markers: proliferating cell nuclear antigen, bromodeoxyuridine, Ki-67, nucleolar organizer regions, and DNA flow cytometry.
Main Results:
- Specific molecular events in gliomas were compared.
- Chromosome 22 alterations were correlated with meningioma histologic features.
- Various proliferation measurement methods are being compared for clinical outcome correlation.
Conclusions:
- Understanding molecular alterations is crucial for predicting brain tumor behavior and response to therapy.
- Validation of proliferation markers is ongoing to identify the most relevant ones for clinical application.
- Further studies are needed to fully characterize neurocytoma and its place among cerebral neuronal tumors.